news
India's Bold Step Towards Biopharma Dominance in Budget 2026-27
The Union Budget 2026-27 of India has introduced the Biopharma SHAKTI initiative, a significant move aimed at transforming India into a global hub for biopharmaceuticals. This initiative, with an outlay of Rs. 10,000 crores over five years, is designed to boost domestic production and development of biologics and biosimilars,